IDH1 and cancer: The results demonstrate that the risk score established by the miRNA expression was more effective at distinguishing DFS time than other criteria that are traditionally used to distinguish disease status, including Kamofsky score, tumor location, recurrence status, MGMT methylation, IDH1 mutation, smoking and family history of cancer.